Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 144 (1) , 73-80
- https://doi.org/10.1067/mhj.2002.123112
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Effect of Weight, Sex, Age, Clinical Diagnosis, and Thromboplastin Reagent on Steady-state Intravenous Heparin RequirementsArchives of internal medicine (1960), 1997
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 1996
- Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)Journal of the American College of Cardiology, 1992
- Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patencyJournal of the American College of Cardiology, 1992
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable anginaThe Lancet, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988